Pristupa Z B, McConkey F, Liu F, Man H Y, Lee F J, Wang Y T, Niznik H B
Department of Psychiatry, University of Toronto, Ontario, Canada.
Synapse. 1998 Sep;30(1):79-87. doi: 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.0.CO;2-K.
Modification of the transport velocity of both the native neuronal and cloned presynaptic dopamine transporter (DAT) has been reported following activation/inhibition of second messenger system pathways. In order to identify the mechanism by which the functional activity of human DAT (hDAT) is regulated, we assessed the [3H]dopamine uptake kinetics, [3H] CFT binding characteristics, and, via immunofluorescent confocal microscopy, the cellular localization profiles of the hDAT expressed in both Sf9 and COS-7 cells following modulation of protein kinase C (PKC)- and protein kinase A (PKA)-dependent pathways. As with both native neuronal and cloned DATs, acute exposure of hDAT expressing Sf9 cells to the PKC activator PMA (1 microM), but not alphaPDD, reduced the Vmax (approximately 1 pmol/min/10(5) cells) for [3H]DA uptake by approximately 40%, an effect which was blocked by the protein kinase inhibitor staurosporine. Pretreatment of cells with staurosporine (500 nM) alone, however, increased [3H]DA uptake velocity by approximately 30%, an effect mimicked by the potent PKA inhibitor Rp-cAMPS. Activation of PKA-dependent pathways with Sp-cAMPS did not significantly modify DA uptake. Neither the Km of [3H]DA uptake (approximately 200 nM) nor the affinity of various substrates and transport inhibitors was altered by either PMA or staurosporine treatment. Despite changes in functional dopamine uptake velocity by PKC/PKA-dependent mechanisms, the estimated density of hDAT as indexed by whole-cell [3H] CFT binding was unchanged. Immunofluorescent confocal microscopy demonstrated that the observed functional consequence of PKC activation on [3H]DA uptake is associated with the rapid sequestration/internalization of hDAT protein from the cell surface, while the increase in DA uptake following PKC/PKA inhibition is the result of the recruitment of internalized or intracellular transporters to the plasma membrane. Identical rapid translocation patterns were observed in similarly treated COS-7 cells transiently expressing hDAT. These data suggest that the differential regulation of DAT transport capacity by both PKC- and PKA-dependent pathways are not a result of modifications in DAT catalytic activity. Moreover, the rapid shuttling of DATs between the plasma membrane and intracellular compartments provides an efficient means by which native DAT function may be regulated by second messenger systems, possibly following activation of presynaptic dopaminergic receptors, and suggests a role for cytoskeletal components in the dynamic regulation of DAT function.
已有报道称,在第二信使系统途径被激活/抑制后,天然神经元和克隆的突触前多巴胺转运体(DAT)的转运速度会发生改变。为了确定人类DAT(hDAT)功能活性的调节机制,我们评估了[3H]多巴胺摄取动力学、[3H]CFT结合特性,并通过免疫荧光共聚焦显微镜,观察了在蛋白激酶C(PKC)和蛋白激酶A(PKA)依赖性途径被调节后,在Sf9和COS-7细胞中表达的hDAT的细胞定位情况。与天然神经元和克隆的DAT一样,将表达hDAT的Sf9细胞急性暴露于PKC激活剂PMA(1μM),而非αPDD,会使[3H]DA摄取的Vmax(约1 pmol/分钟/10(5)个细胞)降低约40%,蛋白激酶抑制剂星形孢菌素可阻断这一效应。然而,单独用星形孢菌素(500 nM)预处理细胞,会使[3H]DA摄取速度增加约30%,强效PKA抑制剂Rp-cAMPS也可模拟这一效应。用Sp-cAMPS激活PKA依赖性途径并不会显著改变DA摄取。PMA或星形孢菌素处理均未改变[3H]DA摄取的Km(约200 nM),也未改变各种底物和转运抑制剂的亲和力。尽管PKC/PKA依赖性机制改变了功能性多巴胺摄取速度,但通过全细胞[3H]CFT结合所测得的hDAT估计密度并未改变。免疫荧光共聚焦显微镜显示,观察到的PKC激活对[3H]DA摄取的功能影响与hDAT蛋白从细胞表面快速隔离/内化有关,而PKC/PKA抑制后DA摄取增加是内化或细胞内转运体被招募到质膜的结果。在类似处理的瞬时表达hDAT的COS-7细胞中也观察到了相同的快速转位模式。这些数据表明,PKC和PKA依赖性途径对DAT转运能力的差异调节并非DAT催化活性改变的结果。此外,DAT在质膜和细胞内区室之间的快速穿梭提供了一种有效的方式,通过这种方式,天然DAT功能可能受第二信使系统调节,可能是在突触前多巴胺能受体激活之后,并提示细胞骨架成分在DAT功能的动态调节中发挥作用。